Reversible posterior leukoencephalopathy syndrome and anti-neoplastic agents: A review

Oncology Reviews

Volumn 1, Issue 3, 2007, Pages 152-161

  Shah Khan, Farheen M ^a   Pinedo, Daryl ^b   Shah, Prabodh ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

(PRES); Chemotherapy" and "MRI; Posterior reversible encephalopathy syndrome; RPLS

Indexed keywords

EID: 62549087614     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-007-0018-0     Document Type: Review

References (76)

1. Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494-500 (Pubitemid 26067737)
2. Cain MS, Burton GV, Holcombe RF (1998) Fatal leukoencephalopathy in a patient with non-Hodgkin's lymphoma treated with CHOP chemotherapy and high dose steroids. Am J Med Sci 315:202-07 (Pubitemid 28125610)
3. Delanty N, Vaughan C, Frucht S, Stubgen P (1997) Erythropoietin associated hypertensive posterior leukoencephalopathy. Neurology 49:686-689 (Pubitemid 27428005)
4. Edwards MJ, Walker R, Vinnicombe S et al (2001) Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol 59:1895-1904
5. Greenwood MJ, Dodds AJ, Garricik R, Rodriguez M (2003) Posterior leukoencephalopathy in association with tumor lysis syndrome in acute lymphoblastic leukemia-a case with clinicopathological correlation. Leuk Lymphoma 44:719-721 (Pubitemid 36304833)
6. Rathi B, Azad RK, Vasudha N et al (2002) L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia. Pediatr Neurosurg 37:203-205 (Pubitemid 35316916)
7. Thaipisuttikul I, Phanthumchinda A (2005) Recurrent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus. J Neurol 252:230-231 (Pubitemid 40385601)
8. Yong PF, Hamour SM, Burns A (2003) Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/ systemic lupus erythematosus overlap syndrome. Nephrol Dial Transplant 18:2660-2662 (Pubitemid 37483804)
9. Kawano H, Kimura E, Ishizaki M et al (2002) Reversible posterior leukoencephalopathy syndrome in two patients with microscopic polyarteritis nodosa. Rinsho Shinkeigaku 42:949-453
10. Hodson AK, Doughty RA, Norman ME (1978) Acute encephalopathy, streptococcal infection, and cryoglobulinemia. Arch Neurol 35:43-44 (Pubitemid 8267700)
11. Ohta T, Sakano T, Shiotsu M et al (2004) Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis. Pediatr Nephrol 19:442-444 (Pubitemid 38477410)
12. Finocchi V, Bozzao A, Bonamini M et al (2005) Magnetic resonance imaging in posterior reversible encephalopathy syndrome: a report of three cases and review of literature. Arch Gynecol Obstet 271:79-85 (Pubitemid 40174585)
13. Sylvester SL, Diaz LA Jr, Port JD, Sterling TR (2002) Reversible posterior leukoencephalopathy in an HIVinfected patient with thrombotic thrombocytopenic purpura. Scand J Infect Dis 34:706-709
14. Sasayama D, Shimojima Y, Gono T et al (2007) Henoch-Schonlein purpura nephritis complicated by reversible posterior leukoencephalopathy syndrome. Clin Rheumatol [In press]
15. Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F (1998) Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis Am J Neuroradiol 19:859-862 (Pubitemid 30415767)
16. Celik M, Forta H, Dalkilic T, Babacan G (2002) MRI reveals reversible lesions resembling posterior reversible encephalopathy in porphyria. Neuroradiology 44:839-841 (Pubitemid 36067877)
17. Tanioka R, Yamamoto Y, Sakai M et al (2007) Convalescence of atypical reversible posterior leukoencephalopathy syndrome in human immunodeficiency virus infection. J Med Invest 54:191-194 (Pubitemid 46769083)
18. Kastrup O, Maschke M, Wanke I, Diener HC (2002) Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 249:1563-1566 (Pubitemid 35477899)
19. Ozyurek H, Oguz G, Ozen S et al (2005) Reversible posterior leukoencephalopathy syndrome: report of three cases. J Child Neurol 20:990-993
20. Ito Y, Arahata Y, Goto Y et al (1998) Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. Am J Neuroradiol 19:415-417 (Pubitemid 30422741)
21. Morrow MJ (1998) Erythropoietinassociated hypertensive posterior leukoencephalopathy. Neurology 51:651
22. Rodriguez Gomez E, Rodriguez Gomez FJ, Merino MJ et al (2001) Reversible posterior leukoencephalopathy, severe hypertension, and cocaine abuse. Nefrologia 21:305-308
23. Rodriguez-Uranga JJ, Franco-Macias E, Bernal Sanchez-Arjona M, Villalobos-Chavez F (2003) Posterior reversible leukoencephalopathy syndrome, pheochromocytoma and von Hippel-Lindau disease Rev Neurol 37:797-798 (Pubitemid 37368889)
24. Ito Y, Niwa H, Iida T et al (1997) Posttransfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology 49:1174-1175 (Pubitemid 27456113)
25. Aydin K, Elmas S, Guzes EA (2006) Reversible posterior leukoencephalopathy and Adie's pupil after measles vaccination. J Child Neurol 21:525-527 (Pubitemid 44069805)
26. Soylu A, Kavukcu S, Turkmen M, Akbas Y (2001) Posterior leukoencephalopathy syndrome in post-streptococcal acute glomerulonephritis. Pediatr Nephrol 16:601-603 (Pubitemid 32600168)
27. Leniger T, Kastrup O, Diener HC (2000) Reversible posterior leukencephalopathy syndrome induced by granulocyte stimulating factor filgrastim. J Neurol Neurosurg Psychiatry 69:280-281 (Pubitemid 30466049)
28. Russell MT, Nassif AS, Cacayorin ED et al (2001) Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn Reson Imaging 19:129-132 (Pubitemid 32274125)
29. Moore D (2003) Toxic leukoencephalopathy: a review and report of two chemotherapy-related cases. Clin J Oncol Nurs 7:413-417
30. Mavragani CP, Vlachoyiannopoulos PG, Kosmas N et al (2004) A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. Rheumatology (Oxford) 43:1450-1451 (Pubitemid 39480939)
31. Saito B, Nakamaki T, Nakashima H et al (2007) Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia. Am J Hematol 82:304-306 (Pubitemid 46564327)
32. Renard D, Westhovens R, Vandenbussche E, Vandenberghe R (2004) Reversible posterior leucoencephalopathy during oral treatment with methotrexate. J Neurol 251:226-228 (Pubitemid 38221640)
33. Glusker P, Recht L, Lane B (2006) Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 354:980-982
34. Ozcan C, Wong SJ, Hari P (2006) Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 354:980-982
35. Govindarajan R, Adusumilli J, Baxter DL et al (2006) Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006. J Clin Oncol 24:e48.
36. Cooney MJ, Bradley WG, Symko SC et al (2000) Hypertensive encephalopathy: complication in children treated for myeloproliferative disorders-report of three cases. Radiology 214:711-716 (Pubitemid 30115369)
37. Honkaniemi J, Kahara V, Dastidar P et al (2000) Reversible posterior leukoencephalopathy after combination chemotherapy. Neuroradiology 42:895-899 (Pubitemid 32015617)
38. Sueblinvong T, Noophun P, Pataradool K et al (2002) Posterior leukoencephalopathy following cisplatin, bleomycin and vinblastine therapy for germ cell tumor of the ovary. J Obstet Gynaecol Res 28:99-103 (Pubitemid 34732561)
39. Cossaart N, SantaCruz KS, Preston D et al (2003) Fatal chemotherapyinduced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature. Bone Marrow Transplant 31:57-60 (Pubitemid 36181823)
40. Tam CS, Galanos J, Seymour JF et al (2004) Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol 77:72-76 (Pubitemid 39108801)
41. Abali H, Eren OO, Dizdar O et al (2005) Posterior leukoencephalopathy after combination chemotherapy in a patient with lymphoma. Leuk Lymphoma 46:1825-1828 (Pubitemid 43203120)
42. Kaito E, Terae S, Kobayashi R et al (2005) The role of tumor lysis in reversible posterior leukoencephalopathy syndrome. Pediatr Radiol 35:722-727 (Pubitemid 40909168)
43. Niyadurupola N, Burnett CA, Allen LE (2005) Reversible posterior leucoencephalopathy syndrome: a cause of temporary cortical blindness. Br J Ophthalmol 89:924-925 (Pubitemid 40904827)
44. Pasupuleti DV, Miranda M, Vattipally V (2005) Case report: posterior reversible encephalopathy syndrome. Am Fam Physician 72:2430-2436
45. Rangi PS, Partridge WJ, Newlands ES, Waldman AD (2005) Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia. Neuroradiology 47:586-590 (Pubitemid 41258706)
46. Stott VL, Hurrell MA, Anderson TJ (2005). Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 35:83-90
47. Allen JA, Adlakha A, Bergethon PR (2006) Reversible posterior leukoencephalopathy syndrome after bevacizumab/ FOLFIRI regimen for metastatic colon cancer. Arch Neurol 63:1475-1478 (Pubitemid 44547561)
48. Connolly RM, Doherty CP, Beddy P, O'byrne K (2007) Chemotherapy induced reversible posterior leukoencephalopathy syndrome. Lung Cancer 56:459-463 (Pubitemid 46679083)
49. Keyserling HF, Provenzale JM (2007) Atypical imaging findings in a nearfatal case of posterior reversible encephalopathy syndrome in a child. Am J Roentgenol 188:219-221 (Pubitemid 46012512)
50. Moris G, Ribacoba R, Gonzalez C (2007) Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine. J Neurol 254:534-535 (Pubitemid 46786705)
51. Skelton MR, Goldberg RM, O'Neil BH (2007) A case of oxaliplatin-related posterior reversible encephalopathy syndrome. Clin Colorectal Cancer 6:386-388 (Pubitemid 46340206)
52. Pinedo D, Shah-Khan F, Shah P (2007) Reversible posterior leukoencephalopathy and oxaliplatin case report. J Clin Oncol 2007; in press.
53. Asato R, Akiyama Y, Ito M et al (1992) Nuclear magnetic resonance abnormalities of the cerebral white matter with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 70:1997-2004
54. Robertson DM, Dinsdale HB, Ayashi T, Tu J (1970) Cerebral lesions in adrenal regeneration hypertension. Am J Pathol 59:115-132
55. Dinsdale HB, Robertson DM, Chiang TY, Mukherjee SK (1971-72) Hypertensive cerebral microinfarction and cerebrovascular reactivity. Eur Neurol 6:29-33
56. Beausang-Linder M, Bill A (1981) Cerebral circulation in acute arterial hypertension-protective effects of sympathetic nervous activity. Acta Physiol Scand 111:193-199 (Pubitemid 11134146)
57. Edvinsson L, Owman C, Sjoberg NO (1976) Autonomic nerves, mast cells and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 115:377-393
58. Serkova NJ, Christians U, Benet LZ (2002) Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 4:97-107 (Pubitemid 38584972)
59. Cooper DK, Novitzky D, Davis L et al (1989) Does central nervous system toxicity occur in transplant patients with hypocholesterolemia receiving cyclosporine? J Heart Transplant 8: 221-224 (Pubitemid 19151664)
60. Thompson CB, Sullivan KM, June CH, Thomas ED (1984) Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 2:1116-1120 (Pubitemid 15210846)
61. Garcia-Escrig M, Martinez J, Fernandez-Ponsati J et al (1994) Severe central nervous toxicity after chronic treatment with cyclosporine. Clin neuropharmacol 17:298-302 (Pubitemid 24170820)
62. Truwit CL, Denaro CP, Lake JR, Demarco T (1991) MR imaging of reversible cyclosporin A- induced neurotoxicity. Am J Neuroradiol 12:651-659
63. Calne RY, Rolles K, White DJ et al (1979) Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 2:1033-1036 (Pubitemid 10213970)
64. Kunzendorf U, Brockmoller J, Jochimsen F et al (1998). Cyclosporin metabolites and central-nervous-system toxicity. Lancet 1:1223-1224
65. Kunzendorf U, Brockmoller J, Jochimsen F et al (1989) Neurotoxicity caused by high cyclosporine metabolite level. Transplantation 48:531-532 (Pubitemid 19236533)
66. Serkova N, Klawitter J, Niemann CU (2003) Organ specific response to inhibition of mitochondrial metabolism by cyclosporine in the rat. Transp Int 16: 748-755 (Pubitemid 37408597)
67. Kitaguchi H, Tomimoto H, Miki Y et al (2005) A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology 47: 652-656 (Pubitemid 41403606)
68. Johansson BB(1983) The blood brain barrier and cerebral blood flow in acute hypertension. Acta Med Scand Suppl. 678:107-112 (Pubitemid 14155333)
69. Ikeda M, Ito S, Hataya H et al (2001) Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome. Am J Kidney Dis 37:e30
70. Lanzino G, Cloft H, Hemstreet MK et al (1997) Reversible posterior leukoencephalopathy following organ transplantation: description of two cases. Clin Neurol Neurosurg 99:222-226 (Pubitemid 27412449)
71. Kwon S, Koo J, Lee S (2001) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 24:361-364
72. Cersosimo, RJ (2005) Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 39:128-135 (Pubitemid 40052388)
73. Extra J-M, Marty M, Brienza S, Misset J-L (1998) Pharmacokinetics and safety profile of oxaliplatin. Semin Oncol 25:13-22 (Pubitemid 28248697)
74. Adelsberger H, Quasthoff S, Grosskreutz J et al (2000) The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neuron. Eur J Pharmacol 406:25-32
75. Wilson RH, Lehky T, Thomas RR et al (2002) Acute oxaliplatin-induced peripheral nerve hyperexcitability. J Clin Oncol 20:1767-1774 (Pubitemid 34273265)
76. Steeghs N, de Jongh FE, Sillevis Smitt PA, van den Bent MJ (2003) Cisplatininduced encephalopathy and seizures. Anticancer Drugs 14:443-446